Huaan Menkul Kıymetler: Geleneksel Çin tıbbı endüstrisi şu anda bir dönüm noktasında ve sektörün geri çekilmesi yeterli ve dibe dönüş için bir fırsat var

Golden Ten Data News on August 5th, Huaxin Securities research report pointed out that the traditional Chinese medicine industry is currently at a turning point, with continued policy support, withdrawal from the region is sufficient, and there is an opportunity for bottoming out. The market’s concerns about same-price policies and centralized procurement have limited impact on most traditional Chinese medicine companies. The latest standardization policy for traditional Chinese medicine shows the top-level design’s emphasis on traditional Chinese medicine. The second-quarter performance is expected to accelerate and reverse under a low base, and the current valuation of traditional Chinese medicine regions highlights cost-effectiveness.